+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GABA Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934283
The latest market analysis report by the publisher reveals a significant surge in global sales of GABA (gamma-aminobutyric acid) supplements, reaching US$44 million in 2024. With a projected growth rate of 8.0% from 2024 to 2031, the market is expected to soar to a valuation of US$74 million by the end of the forecast period. Capsules are anticipated to lead in revenue generation, with a robust CAGR of over 5.5% during the forecast period.

Key Drivers Influencing Market Expansion

  • Addressing Sleep Disorders and Anxiety: GABA supplements offer relaxation to the brain, reducing stress levels, improving sleep quality, and alleviating anxiety and hormonal irritability. With a substantial portion of the global population experiencing insomnia and anxiety-related issues, the demand for dietary supplements promoting relaxation is on the rise.
  • Impact of Covid-19 on Mental Health: The pandemic has led to a significant increase in anxiety and depression worldwide. GABA supplements, known for their neurotransmitter support, are sought after as dietary supplements to alleviate anxiety and promote mental wellness.
  • Management of Premenstrual Dysphoric Disorder (PMDD): Women facing PMDD, characterized by anxiety, depression, mood swings, and irritability, are turning to dietary supplements for relief. GABA supplements offer a promising solution to improve mood and reduce inflammation associated with PMDD.
  • Blood Pressure Management: Studies indicate that GABA supplements may help stabilize blood pressure levels, presenting a potential solution for individuals with hypertension and related health concerns.
  • Support for Neurological Disorders: People with conditions like Parkinson’s disease, hyperactivity disorder, and seizure disorders may benefit from GABA supplements, which produce calming effects to reduce anxiety.

Region-wise Market Projections

1. United States: The United States GABA supplements market is poised to witness substantial growth, driven by increasing awareness and demand for anxiety management solutions. With anxiety disorders affecting a significant portion of the population, there's a growing preference for dietary supplements as a complementary approach. This trend presents a lucrative opportunity for the GABA supplements market in the U.S.

2. United Kingdom: In the United Kingdom, the market for GABA supplements is anticipated to experience steady growth. The impact of events like the Covid-19 pandemic has heightened the prevalence of anxiety and depression, leading individuals to seek alternative solutions such as GABA supplements. The accessibility and non-harmful nature of these supplements make them an attractive option for managing sleep and anxiety-related issues.

3. Japan: Japan's GABA supplements market is expected to witness significant growth, fueled by a rising prevalence of sleep disorders. With a considerable portion of the population experiencing insomnia and other sleep-related issues, there's a growing demand for effective solutions. GABA supplements offer a promising option for addressing sleep problems, contributing to the market's expansion in Japan.

4. China: The GABA supplements market in China is poised for substantial growth, driven by a high prevalence of sleep disorders among the population. As sleep-related issues continue to affect millions of individuals in the country, there's a growing inclination towards dietary supplements for improving sleep quality. This trend presents significant opportunities for the GABA supplements market in China.

5. South Korea: South Korea's GABA supplements market is expected to witness robust growth, driven by increasing awareness of stress management and skincare benefits associated with good sleep. With stress levels being a concern for a significant portion of the population, there's a growing demand for relaxation and stress reduction solutions. Additionally, the association between quality sleep and skin health further boosts the demand for GABA supplements in South Korea.

Form-wise Growth Insights

Capsules: Demand for GABA supplements in capsule form is expected to witness significant growth, driven by its effectiveness and convenience.

Competitive Analysis

Key players in the GABA supplements market include Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, Integrative Therapeutics, Solgar, and Nusa Pure. These companies offer a range of GABA supplements in various forms and provide consumer-centric support through stress tests and quizzes on their websites.

Segmentation of the GABA Supplements Market:

By Form:

  • Capsules
  • Lozenges
  • Powder
  • Gummies

By Distribution Channel:

  • Online Stores
  • Pharmacies
  • Supermarkets
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global GABA Supplements Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global GABA Supplements Market Outlook, 2018 - 2031
3.1. Global GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Capsules
3.1.1.2. Lozenges
3.1.1.3. Powder
3.1.1.4. Gummies
3.2. Global GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Online Stores
3.2.1.2. Pharmacies
3.2.1.3. Supermarkets
3.2.1.4. Others
3.3. Global GABA Supplements Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America GABA Supplements Market Outlook, 2018 - 2031
4.1. North America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Capsules
4.1.1.2. Lozenges
4.1.1.3. Powder
4.1.1.4. Gummies
4.2. North America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Online Stores
4.2.1.2. Pharmacies
4.2.1.3. Supermarkets
4.2.1.4. Others
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe GABA Supplements Market Outlook, 2018 - 2031
5.1. Europe GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Capsules
5.1.1.2. Lozenges
5.1.1.3. Powder
5.1.1.4. Gummies
5.2. Europe GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Online Stores
5.2.1.2. Pharmacies
5.2.1.3. Supermarkets
5.2.1.4. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.5. France GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.6. France GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.7. Italy GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific GABA Supplements Market Outlook, 2018 - 2031
6.1. Asia Pacific GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Capsules
6.1.1.2. Lozenges
6.1.1.3. Powder
6.1.1.4. Gummies
6.2. Asia Pacific GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Online Stores
6.2.1.2. Pharmacies
6.2.1.3. Supermarkets
6.2.1.4. Others
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.2. China GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.7. India GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.8. India GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America GABA Supplements Market Outlook, 2018 - 2031
7.1. Latin America GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Capsules
7.1.1.2. Lozenges
7.1.1.3. Powder
7.1.1.4. Gummies
7.2. Latin America GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Online Stores
7.2.1.2. Pharmacies
7.2.1.3. Supermarkets
7.2.1.4. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa GABA Supplements Market Outlook, 2018 - 2031
8.1. Middle East & Africa GABA Supplements Market Outlook, by Form, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Capsules
8.1.1.2. Lozenges
8.1.1.3. Powder
8.1.1.4. Gummies
8.2. Middle East & Africa GABA Supplements Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Online Stores
8.2.1.2. Pharmacies
8.2.1.3. Supermarkets
8.2.1.4. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa GABA Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa GABA Supplements Market by Form, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa GABA Supplements Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2023
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Now Foods
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Horbaach
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Pure Encapsulations
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Nutrabio
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Thorne
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Vitanica
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Country Life
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Integrative Therapeutics
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Solgar
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Now Foods
  • Horbaach
  • Pure Encapsulations
  • Nutrabio
  • Thorne
  • Vitanica
  • Country Life
  • Integrative Therapeutics
  • Solgar

Methodology

Loading
LOADING...